Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

Entrada successful completion of a $116 million Series B financing

April 1, 2021

Entrada successful completion of a $116 million Series B financing

Dehua Pei

Entrada Therapeutics just announced the successful completion of a $116 million Series B financing. Entrada is a privately-held biotechnology company dedicated to transforming the treatment of devastating diseases using intracellular biologics. This company was started in part by our own, Professor, Dehua Pei.

To read the full article: https://www.entradatx.com/news/entrada-therapeutics-announces-closing-of-116-million-series-b-financing 

News Filters:

Faculty Awards